Pfizer and Viatris use registration to expand availability of on-patent antibiotics in low- and middle-income countries

Pfizer and Viatris have each expanded registration of specific on-patent medicines in more than 15 low- and middle-income countries since the last Benchmark.

Explore further

Get in touch

Back to top |